KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Operating Income (2016 - 2025)

LifeMD (LFMD) has disclosed Operating Income for 14 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income rose 44.89% year-over-year to -$1.8 million, compared with a TTM value of -$7.7 million through Dec 2025, up 61.09%, and an annual FY2025 reading of -$7.7 million, up 62.41% over the prior year.
  • Operating Income was -$1.8 million for Q4 2025 at LifeMD, up from -$2.0 million in the prior quarter.
  • Across five years, Operating Income topped out at -$1.6 million in Q1 2025 and bottomed at -$16.1 million in Q2 2021.
  • Average Operating Income over 5 years is -$7.0 million, with a median of -$5.5 million recorded in 2023.
  • The sharpest move saw Operating Income crashed 584.76% in 2021, then soared 78.23% in 2023.
  • Year by year, Operating Income stood at -$13.7 million in 2021, then skyrocketed by 42.3% to -$7.9 million in 2022, then skyrocketed by 72.46% to -$2.2 million in 2023, then crashed by 49.16% to -$3.2 million in 2024, then surged by 44.89% to -$1.8 million in 2025.
  • Business Quant data shows Operating Income for LFMD at -$1.8 million in Q4 2025, -$2.0 million in Q3 2025, and -$2.3 million in Q2 2025.